Jonathon Tomlinson considers his options as a GP supporting people with depression and complex needs, after reading a new systematic review and dose-response meta-analysis, which suggests that higher doses of antidepressants bring maximum side effects with only marginal gains.
[read the full story...]
A group of UCL Masters Students summarise a recent personal view by Mark Horowitz and David Taylor about tapering of SSRI treatment to mitigate antidepressant withdrawal symptoms.
[read the full story...]
Luke Sheridan-Reins explores a recent paper on the contribution of cannabis use to variation in the incidence of psychotic disorder across Europe.
[read the full story...]
Leela Sathyaputri and Jess Fiedorowicz write their debut elf blog on a narrative review of the recent bipolar disorder literature entitled: “Areas of uncertainties and unmet needs in bipolar disorders: clinical and research perspectives”.
[read the full story...]
Ian Cummins explores a recent international systematic review and meta-analysis, which highlights ethnic variations in compulsory detention under the Mental Health Act.
[read the full story...]
David Shiers and Peter Byrne summarise the new SCIMITAR+ trial out today in The Lancet Psychiatry, which evaluates a bespoke smoking cessation intervention for people with severe mental illness.
[read the full story...]
Robyn Murphy summarises an RCT that compares the effectiveness and cost-effectiveness of an intensive community supported discharge service versus treatment as usual for adolescents with psychiatric emergencies.
[read the full story...]
Simon Bradstreet welcomes the positive findings of the REFOCUS-PULSAR trial, which evaluated recovery-oriented practice training in specialist mental health care.
[read the full story...]
John Baker explores a systematic review of compulsory community treatment to reduce readmission to hospital and increase engagement with community care in people with mental illness.
[read the full story...]
Dean Connolly is impressed by a recent systematic review and network meta-analysis, which compares the efficacy and tolerability of medication for ADHD in children, young people and adults.
[read the full story...]
